Targeting leukemia’s “fatty tooth”

In this issue of Blood , [Ricciardi et al][1] report a novel fatty acid oxidation (FAO) inhibitor, ST1326, that effectively inhibits proliferation, survival, and chemoresistance in leukemia cell lines and primary samples.[1][2] ![Figure][3] FAO supports mitochondrial function and integrity